N-Nitroso Donepezil EP Impurity A/N-Nitroso Donepezil Desbenzyl Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Donepezil is used to treat dementia (memory loss and mental changes) associated with mild, moderate, or severe Alzheimer's disease. Donepezil will not cure Alzheimer's disease, and it will not stop the disease from getting worse. However, it can improve thinking ability in some patients. N-Nitroso Donepezil EP Impurity A is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Donepezil EP Impurity A is also known as N-Nitroso Donepezil Desbenzyl Impurity and chemically represented as 5,6-dimethoxy-2-((1-nitrosopiperidin-4-yl)methyl)-2,3-dihydro-1H-inden-1- one. Synchemia is the leading manufacturing and exporter of N-Nitroso Donepezil EP Impurity A.We supply N-Nitroso Donepezil EP Impurity A with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143796 |
| CAS No | NA |
| Mol.F. | C8H7F3N4O5S2 |
| Mol.Wt. | 360.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143797 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143798 |
| CAS No | NA |
| Mol.F. | C15H18N2O4 |
| Mol.Wt. | 290.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143799 |
| CAS No | 2639422-25-4 |
| Mol.F. | C10H19N3O |
| Mol.Wt. | 197.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143800 |
| CAS No | NA |
| Mol.F. | C8H14N2O5 |
| Mol.Wt. | 218.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143801 |
| CAS No | NA |
| Mol.F. | C8H15N3O4 |
| Mol.Wt. | 217.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143802 |
| CAS No | NA |
| Mol.F. | C8H14ClN3O3 |
| Mol.Wt. | 235.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143803 |
| CAS No | NA |
| Mol.F. | C17H9D8FN4O5 |
| Mol.Wt. | 384.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143804 |
| CAS No | NA |
| Mol.F. | C34H39N7O7 |
| Mol.Wt. | 657.7 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143805 |
| CAS No | NA |
| Mol.F. | C12H12D5N3O2 |
| Mol.Wt. | 240.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143806 |
| CAS No | NA |
| Mol.F. | C10H19D4N3O3 |
| Mol.Wt. | 237.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143807 |
| CAS No | NA |
| Mol.F. | C10H18D4N4O4 |
| Mol.Wt. | 266.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143808 |
| CAS No | NA |
| Mol.F. | C10H22N215N2O4 |
| Mol.Wt. | 264.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143809 |
| CAS No | NA |
| Mol.F. | C10H23N215NO3 |
| Mol.Wt. | 234.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143810 |
| CAS No | NA |
| Mol.F. | C17H14D3F3N2O2 |
| Mol.Wt. | 341.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143811 |
| CAS No | NA |
| Mol.F. | C17H12D5F3N2O2 |
| Mol.Wt. | 343.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |